News

Endpoints News6d
Arv­inas, Pfiz­er's PRO­TAC in breast can­cer no bet­ter than oral SERDs
Arvinas' vepdegestrant shows 43% reduced risk of progression or death in ESR1-mutated breast cancer patients vs hormone ...
ENDPOINTS NEWS7d
Q&A: Why for­mer Sen. Kyrsten Sine­ma is back­ing a psy­che­del­ic med­i­cine with po­ten­tial­ly more up­side, but more risk
It may not come as a sur­prise that one of the most un­con­ven­tion­al US sen­a­tors in re­cent mem­o­ry has tak­en a keen in­ter­est in a … ...